Boston Scientific Accumulated Depreciation increased by 2.1% to $3.86B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 6.6%, from $3.62B to $3.86B. Over 4 years (FY 2020 to FY 2024), Accumulated Depreciation shows relatively stable performance with a 2.3% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
A rising balance relative to gross assets suggests an aging infrastructure, potentially signaling a need for future capital expenditure to replace equipment.
This is the cumulative amount of depreciation expense charged against the company's tangible assets since their acquisit...
Commonly found in the balance sheet or notes for all companies with significant physical property, plant, and equipment.
ppe_accumulated_depreciation| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.31B | $3.31B | $3.27B | $3.30B | $3.27B | $3.19B | $3.28B | $3.36B | $3.43B | $3.45B | $3.48B | $3.53B | $3.56B | $3.62B | $3.53B | $3.64B | $3.78B | $3.86B |
| QoQ Change | — | +0.0% | -1.2% | +0.8% | -1.0% | -2.4% | +2.9% | +2.3% | +2.1% | +0.5% | +1.1% | +1.3% | +0.9% | +1.7% | -2.5% | +3.1% | +3.9% | +2.1% |
| YoY Change | — | — | — | — | -1.4% | -3.7% | +0.3% | +1.8% | +4.9% | +8.0% | +6.2% | +5.1% | +3.9% | +5.1% | +1.4% | +3.2% | +6.2% | +6.6% |
| % of PP&E (Net) | 159.1% | 157.1% | 145.3% | 145.7% | 145.5% | 140.3% | 134.2% | 135.6% | 135.3% | 130.8% | 121.9% | 121.9% | 120.7% | 117.9% | 107.3% | 107.5% | 109.3% | 101.7% |
| Share Change | — | -2.0pp | -11.8pp | +0.4pp | -0.2pp | -5.2pp | -6.2pp | +1.4pp | -0.3pp | -4.5pp | -8.9pp | -0.0pp | -1.2pp | -2.8pp | -10.6pp | +0.2pp | +1.8pp | -7.6pp |